Omega-3

Omega-3 is a 6.5–7.0/10 fit for people using cardiovascular, anti inflammatory, and metabolic health as a measured experiment, not a belief-based staple. The best anchors are Kaviani et al. 2022, which reports umbrella meta-analysis and CRP, IL-6, and TNF-alpha reductions support modest anti-inflammatory effect, and Zhang et al. 2025, which reports 23 randomized trials, 2,061 participants and reduced triglycerides and total cholesterol, no significant plaque-volume effect. That gives Omega-3 a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use Omega-3 when the target is specific, measurable, and worth the tradeoff. Skip or stop Omega-3 when the expected symptom, lab, or performance marker stays flat.

✅ Best for: People with documented low Omega-3 Index below 5%; patients with elevated triglycerides who are using clinician-directed prescription EPA or high-quality EPA/DHA protocols; adults using EPA-dominant omega-3 as an adjunct for unipolar depression; rheumatoid arthritis patients seeking modest pain and NSAID-sparing support; chronic pain patients where inflammation is part of the picture; pregnant or lactating women using purified DHA or algae oil after clinician review; and vegans using direct EPA/DHA algae oil instead of relying on ALA conversion.

❌ Avoid if: You already eat fatty fish 2-3 times weekly and have a solid Omega-3 Index; you have atrial fibrillation, frequent palpitations, or high cardiovascular-risk status and want high-dose omega-3 without clinician oversight; you use warfarin or dual antiplatelet therapy without monitoring; you have fish allergy and are considering fish oil; you have shellfish allergy and are considering krill oil; or you are tempted by bargain fish oil with no third-party freshness testing. Also skip omega-3 if buying capsules becomes a way to avoid fixing diet quality.